scholarly journals Molecular Biology in Basic and Clinical Neuroscience Research

1988 ◽  
Vol 51 (2) ◽  
pp. 322-322
Author(s):  
P. Smith ◽  
C. Hall
E-psychologie ◽  
2021 ◽  
Vol 15 (4) ◽  
pp. 95-97
Author(s):  
Ondřej Bezdíček ◽  
Tomáš Nikolai

The Laboratory of Neuropsychology (LN)—Jiří Diamant Neuropsychological Laboratory—is a generic base for research and teaching of clinical and experimental neuropsychology in close connection with clinical neuroscience research and postgraduate studies in neuroscience and medical psychology and psychopathology at the Department of Neurology. The LN provides medical services and participates in teaching and research as required by the Head of the Dept. of Neurology. The LN is a base for collaboration with external departments, especially in the areas of clinical and medical psychology, health psychology, brain imaging, neurosurgery, and psychopharmacology. The research program of the LN is mainly devoted to the neuropsychology of neurodegenerative diseases and the development of neuropsychological tools for the assessment of neuropsychiatric disorders.


2006 ◽  
Vol 64 (2b) ◽  
pp. 538-542 ◽  
Author(s):  
Ricardo Nitrini

The Brazilian scientific production saw more than a four-fold increase from the 1990s onwards. The aim of this study was to evaluate the evolution of scientific production by Brazilian clinical neuroscientists over the last 10 years. A search in the PubMed identified 295 clinical neuroscientists and their publications. Brazilian production corresponded to 2.37% of the papers published by the 20 indexed periodicals that regularly publish clinical neuroscience research. If only the first and last two years are compared, there was a real growth of 75.1%. More than 40% of the Brazilian papers were published in Arquivos de Neuro-Psiquiatria, the official journal of the Brazilian Academy of Neurology. When only those periodicals with impact factor higher than one are considered, the percentage falls to 0.86% in the whole 10-year period, but attains 1.23% in 2004. Epilepsy and infectious diseases were the sub-areas with the highest scientific production.


2019 ◽  
Vol 3 (2) ◽  
pp. 1-12 ◽  
Author(s):  
Castejón OJ

According to the results of our laboratory the theory of immune dysfunction, the theory on the genetic architecture of ASD, the disrupted cortical connectivity theory and the theory on the contribution of cerebellum to ASD have shown fundamental experimental evidences to support the core symptoms of the complex and enigmatic physiopathology of autism spectrum disorder. The additional hypothesis about the neurogenesis in the amygdala, the contribution of oxytocin, vasopressin, the mirror neuron network, and mitochondrial dysfunction described are stimulating and interesting approaches that deserve further systematic basic and clinical neuroscience research.


2007 ◽  
Vol 4 (3) ◽  
pp. 537-544 ◽  
Author(s):  
Perry D. Cohen ◽  
Linda Herman ◽  
Sheryl Jedlinski ◽  
Peggy Willocks ◽  
Paula Wittekind

2008 ◽  
Vol 34 (1) ◽  
pp. 25-33 ◽  
Author(s):  
Alexander Pozamantir ◽  
Hedok Lee ◽  
Joab Chapman ◽  
Isak Prohovnik

2021 ◽  
Vol 11 ◽  
Author(s):  
Yanan Sui ◽  
Ye Tian ◽  
Wai Kin Daniel Ko ◽  
Zhiyan Wang ◽  
Fumin Jia ◽  
...  

Deep brain stimulation (DBS) is one of the most important clinical therapies for neurological disorders. DBS also has great potential to become a great tool for clinical neuroscience research. Recently, the National Engineering Laboratory for Neuromodulation at Tsinghua University held an international Deep Brain Stimulation Initiative workshop to discuss the cutting-edge technological achievements and clinical applications of DBS. We specifically addressed new clinical approaches and challenges in DBS for movement disorders (Parkinson's disease and dystonia), clinical application toward neurorehabilitation for stroke, and the progress and challenges toward DBS for neuropsychiatric disorders. This review highlighted key developments in (1) neuroimaging, with advancements in 3-Tesla magnetic resonance imaging DBS compatibility for exploration of brain network mechanisms; (2) novel DBS recording capabilities for uncovering disease pathophysiology; and (3) overcoming global healthcare burdens with online-based DBS programming technology for connecting patient communities. The successful event marks a milestone for global collaborative opportunities in clinical development of neuromodulation to treat major neurological disorders.


Sign in / Sign up

Export Citation Format

Share Document